Hybrigenics S.A. (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
28 Pages - GLDATA51013
$250.00

Summary

Hybrigenics S.A. (Hybrigenics) offers research and development of new targets and therapies against proliferative cancerous or non-cancerous diseases. Its lead product candidate is inecalcitol, which is a vitamin D receptor agonist being assessed in three indications including prostate cancer, chronic lymphocytic leukaemia and moderate to severe psoriasis. Hybrigenics ‘research program investigates the action of deubiquitinating enzymes (DUB) in the recycling of onco-proteins and the utility of proprietary patented DUB inhibitors against various cancer indications. The company has expertise in the field of DUBs, which it applies to the discovery and development of new treatments. Hybrigenics Services, the company’s subsidiary, markets specialized scientific services that aid in validating and inhibiting protein interactions in animal, plant or microbiological cells. Hybrigenics is headquartered in Paris, France.

Hybrigenics S.A. (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Hybrigenics S.A., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Hybrigenics Acquires Genomic Division Of Imaxio 10
Hybrigenics Services Acquires Yeast Two-Hybrid Activities Of Dualsystems Biotech 11
Partnerships 12
Hybrigenics Extends Research Agreement with Les Laboratoires Servier 12
Hybrigenics Enters Into Research Agreement With Les Laboratoires Servier 13
Equity Offering 15
Hybrigenics Raises USD7.1 Million in Public Offering 15
Hybrigenics Raises USD2.7 Million in Private Placement 16
Hybrigenics to Raise USD7.6 Million in Rights Offering of Shares 17
Hybrigenics Raises USD6 Million in Private Placement of Shares 18
Hybrigenics Completes Private Placement Of Shares For US$8.4 Million 19
Hybrigenics Completes Private Placement Of Shares For US$4.1 Million 20
Hybrigenics Completes Second Tranche Private Placement Of Shares For US$1.9 Million 21
Hybrigenics Completes Private Placement Of Shares For US$0.35 Million 22
Hybrigenics Completes Private Placement Of Shares For US$3 Million 23
Hybrigenics S.A. - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Hybrigenics S.A., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Hybrigenics S.A., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Hybrigenics S.A., Deals By Therapy Area, 2010 to YTD 2016 8
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Hybrigenics Acquires Genomic Division Of Imaxio 10
Hybrigenics Services Acquires Yeast Two-Hybrid Activities Of Dualsystems Biotech 11
Hybrigenics Extends Research Agreement with Les Laboratoires Servier 12
Hybrigenics Enters Into Research Agreement With Les Laboratoires Servier 13
Hybrigenics Raises USD7.1 Million in Public Offering 15
Hybrigenics Raises USD2.7 Million in Private Placement 16
Hybrigenics to Raise USD7.6 Million in Rights Offering of Shares 17
Hybrigenics Raises USD6 Million in Private Placement of Shares 18
Hybrigenics Completes Private Placement Of Shares For US$8.4 Million 19
Hybrigenics Completes Private Placement Of Shares For US$4.1 Million 20
Hybrigenics Completes Second Tranche Private Placement Of Shares For US$1.9 Million 21
Hybrigenics Completes Private Placement Of Shares For US$0.35 Million 22
Hybrigenics Completes Private Placement Of Shares For US$3 Million 23
Hybrigenics S.A., Key Competitors 25
Hybrigenics S.A., Key Employees 26
Hybrigenics S.A., Subsidiaries 27

List of Figures
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838